SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: SU5416 may stop the growth of cancer cells by stopping blood flow to the tumor.
PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have
advanced or recurrent cancer of the head and neck.